Cargando…
Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema
PURPOSE: The aim of this study was to explore and describe quantitatively patient-reported outcome measures (PROMs), ie, health-related quality of life (QoL), visual function and treatment satisfaction, in patients with diabetic macular edema (DME) receiving two different regimens of Ozurdex (intrav...
Autores principales: | Ramu, Jayashree, Chatziralli, Irini, Yang, Yit, Menon, Geeta, Bailey, Clare, Eckstein, Michael, Hykin, Phil, Sivaprasad, Sobha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364019/ https://www.ncbi.nlm.nih.gov/pubmed/28360511 http://dx.doi.org/10.2147/PPA.S132859 |
Ejemplares similares
-
Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial
por: Hykin, Philip, et al.
Publicado: (2019) -
Pre-operative intravitreal dexamethasone implant in patients with refractory diabetic macular edema undergoing cataract surgery
por: Kabanarou, Stamatina A., et al.
Publicado: (2020) -
INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: Pharmacokinetic Considerations
por: Yang, Yit, et al.
Publicado: (2015) -
Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome
por: Chatziralli, Irini, et al.
Publicado: (2017) -
Predictors of Visual Acuity Outcomes after Anti–Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion
por: Sen, Piyali, et al.
Publicado: (2021)